Rilotumumab
Rilotumumab (AMG 102) is a monoclonal antibody targeting hepatocyte growth factor that inhibits HGF/ MET-driven signaling. Rilotumumab has antitumor effects and can be used to study castration-resistant prostate cancer (CRPC) and gastric cancer.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
C-Met/HGFR
CAS Number
872514-65-3
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1305845-01 0.02 mg (E-Coli)
Recombinant Acinetobacter sp. UPF0234 protein ACIAD3137 (ACIAD3137)
Ask
View Details MBS1305845-02 0.1 mg (E-Coli)
Recombinant Acinetobacter sp. UPF0234 protein ACIAD3137 (ACIAD3137)
Ask
View Details MBS1305845-03 0.02 mg (Yeast)
Recombinant Acinetobacter sp. UPF0234 protein ACIAD3137 (ACIAD3137)
Ask
View Details 
MBS1305845-04 0.1 mg (Yeast)
Recombinant Acinetobacter sp. UPF0234 protein ACIAD3137 (ACIAD3137)
Ask
View Details 
MBS1305845-05 0.02 mg (Baculovirus)
Recombinant Acinetobacter sp. UPF0234 protein ACIAD3137 (ACIAD3137)
Ask
View Details